Tissue Tek O.C.T. Compound

Tissue Tek O.C.T. Compound

Contact us: [email protected]

Compound 401
B7337-25 25 mg
EUR 529.2

Compound 401
B7337-5 5 mg
EUR 216

Compound 401
HY-19341 10mM/1mL
EUR 223.2

Compound 1
1688-5 each
EUR 248.4

Compound W
2208-250 each
EUR 360

Compound W
2208-50 each
EUR 138

Compound 34
1898-1000 each
EUR 548.4

Compound 34
1898-200 each
EUR 189.6

Compound E
1949-1000 each
EUR 444

Compound E
1949-250 each
EUR 183.6

Compound W
A4401-50 50 mg
EUR 212.4
Description: Inhibitor of ?-secretase; causes a decrease in the released levels of A?42 and notch-1 A?-like peptide 25 (N?25).

Compound 56
A8197-.5 500 µg
EUR 129.6
Description: Compound 56, 4-[(3-Bromophenyl)amino]-6,7-diethoxyquinazoline, is a potent and specific inhibitor of the tyrosine kinase of the epidermal growth factor receptor (EGFR) showing an IC50 of 0.006 nM.

Compound 56
A8197-5 5 mg
EUR 268.8
Description: Compound 56, 4-[(3-Bromophenyl)amino]-6,7-diethoxyquinazoline, is a potent and specific inhibitor of the tyrosine kinase of the epidermal growth factor receptor (EGFR) showing an IC50 of 0.006 nM.

Compound 56
A8197-5.1 10 mM (in 1mL DMSO)
EUR 324
Description: Compound 56, 4-[(3-Bromophenyl)amino]-6,7-diethoxyquinazoline, is a potent and specific inhibitor of the tyrosine kinase of the epidermal growth factor receptor (EGFR) showing an IC50 of 0.006 nM.

Compound 56
A8197-S Evaluation Sample
EUR 97.2
Description: Compound 56, 4-[(3-Bromophenyl)amino]-6,7-diethoxyquinazoline, is a potent and specific inhibitor of the tyrosine kinase of the epidermal growth factor receptor (EGFR) showing an IC50 of 0.006 nM.

Compound K
N1890-20 20 mg
EUR 408
Description: Compound K

Compound 34
GL2080-1MG 1 mg
EUR 447.6

Compound 34
GL2080-200UG 200 ug
EUR 199.2

Compound E
GL3746-1MG 1 mg
EUR 453.6

Compound E
GL3746-250UG 250 ug
EUR 206.4

Compound E
GL3746-5MG 5 mg
EUR 1197.6

Compound 2
HY-U00358 10mg
EUR 7249.2

Compound E
HY-14176 10mM/1mL
EUR 832.8

Compound 34
GL2080-1 1
EUR 351.9

Compound 34
GL2080-200 200
EUR 139.6

Compound E
GL3746-1 1
EUR 263.4

Compound E
GL3746-250 250
EUR 133.6

Compound E
GL3746-5 5
EUR 853.3

Compound CL0485
ADC-P-074 unit Ask for price

Compound 112254 hydrochloride
GL8859-10MG 10 mg
EUR 199.2

Compound 112254 hydrochloride
GL8859-50MG 50 mg
EUR 550.8

Compound 112254 hydrochloride
GL8859-10 10
EUR 139.6

Compound 112254 hydrochloride
GL8859-50 50
EUR 440.4

APHA Compound 8
M45003 1 mg
EUR 341.88

Teijin compound 1
B5468-10 10 mg
EUR 466.8

Teijin compound 1
B5468-50 50 mg
EUR 1771.2

GPR120 Compound A
C5824-10 10 mg
EUR 351.6
Description: GPR120 Compound A is an orally active and high-affinity agonist of GPR120 [1].G-protein coupled receptor 120 is a G protein-coupled receptor which has been expressed in intestine, adipocytes, and pro-inflammatory macrophages that is activated by long chain free fatty acids.

GPR120 Compound A
C5824-5 5 mg
EUR 236.4
Description: GPR120 Compound A is an orally active and high-affinity agonist of GPR120 [1].G-protein coupled receptor 120 is a G protein-coupled receptor which has been expressed in intestine, adipocytes, and pro-inflammatory macrophages that is activated by long chain free fatty acids.

GPR120 Compound A
C5824-50 50 mg
EUR 1104
Description: GPR120 Compound A is an orally active and high-affinity agonist of GPR120 [1].G-protein coupled receptor 120 is a G protein-coupled receptor which has been expressed in intestine, adipocytes, and pro-inflammatory macrophages that is activated by long chain free fatty acids.

Teijin compound 1
HY-108323 5mg
EUR 374.4

Imidazoquinoline Compound
VAdv-Ly0028 5 mg
EUR 3936
Description: Imidazoquinoline compound, a TLR7 agonist vaccine adjuvant.

Tissue Tek O.C.T. Compound